Bohus Biotech Ab
Clinical trials sponsored by Bohus Biotech Ab, explained in plain language.
-
New eye gel passes safety test in cataract and glaucoma surgeries
Disease control CompletedThis study tested a gel called MINIVISC® PLUS, used during eye surgeries like cataract removal and glaucoma surgery to protect delicate tissues and keep the eye stable. Researchers checked if the gel was safe and worked well in 134 patients. The main focus was on eye pressure aft…
Phase: NA • Sponsor: Bohus Biotech AB • Aim: Disease control
Last updated Jun 26, 2026 19:01 UTC
-
Cheek filler study shows safety and aesthetic improvement
Symptom relief CompletedThis completed study tested Decoria Voluma, a hyaluronic acid dermal filler, in 111 adults with midface volume deficit. The filler was injected into the cheeks to restore volume. Researchers measured aesthetic improvement using a standard scale and tracked side effects. The goal …
Phase: NA • Sponsor: Bohus Biotech AB • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
New filler study shows smoother smile lines with minimal risk
Symptom relief CompletedThis study tested Decoria intense, a hyaluronic acid filler already on the market, to confirm it safely reduces nasolabial folds (smile lines). About 80 adults with at least moderate wrinkles received the filler, with an optional touch-up. Researchers measured wrinkle severity an…
Phase: NA • Sponsor: Bohus Biotech AB • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Jawline filler passes safety check in 114-Person trial
Symptom relief CompletedThis study tested the safety and effectiveness of Decoria Intense Strong, a filler used to improve the shape of the jawline. 114 adults received the treatment. Doctors found that it safely enhanced jawline contour, with most patients showing noticeable improvement.
Phase: NA • Sponsor: Bohus Biotech AB • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC